The 2022 ASMBS/IFSO guidelines also support consideration in patients with BMI 30 kg/m with metabolic disease
CagriSema is closest to potential approval among GLP-1/amylin combinations
However, if they change in size, shape, or color, a biopsy may be needed to determine if the spot is a symptom of oral cancer
For hair growth, the credible endpoints are well established standardized global photography assessed by blinded evaluators, and target-area hair counts and density measured by trichoscopy or phototrichogram at fixed scalp sites over a sufficient duration (typically 24 weeks or more, because the hair cycle is slow)
Jan 12, 2026 | 3:12 PM Read More Microdosing GLP-1 Medications: Why a Slower Approach Can Lead to Better Results For many people considering GLP-1 medications like semaglutide, the promise of weight loss or metabolic improvement is paired with concern
Reductions in body weight were significantly greater with the LY3298176 1.5 mg, 4.5 mg and 10 mg doses versus placebo in MAD HS (LSM difference [95% CI]: -1.75 kg [-3.38, -0.12], -5.09 kg [-6.72, -3.46] and -4.61 kg [-6.21, -3.01], respectively) and doses of 10 mg and 15 mg had a relevant effect in T2DM patients (LSM difference [95% CI]: -2.62 kg [-3.79, -1.45] and -2.07 kg [-3.25, -0.88], respectively
